United Natural Foods
UNFI NYSE Food Retail Financials FY2017βFY2026
United Natural Foods' revenue fell 2.0% to $31.2 billion in fiscal 2026. Its operating margin was 0.7%, up from β0.1% a year earlier. Free cash flow was $323 million, up 35.1%. It paid out $50 million in dividends and buybacks, 15% of free cash flow. The diluted share count rose 4.3%.
What United Natural Foods does
No business description yet.
- Legal name
- United Natural Foods, Inc.
- Fiscal year ends
- August 1, 2026
- Latest annual report
- β
- Accession Β· CIK
- 0001020859-26-000025
0001020859
Revenue and margins
United Natural Foods had $31.2B of revenue in fiscal 2026, down 2.0% on the year before.
Net income and earnings per share
From fiscal 2017 to 2026, diluted EPS grew β6.9% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $323M in fiscal 2026, 1.0% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
United Natural Foods returned $50.0M to shareholders in fiscal 2026, 15% of free cash flow. The diluted share count rose 4.3%.
Value United Natural Foods yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$1.5B and divides by 62.8M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 35.0x Β· peers 33.7x Β· sector 24.2x.
Balance sheet
Cash, debt and the ratios that show how comfortably United Natural Foods can carry it.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | $44.0M | $37.0M | $40.0M | $44.0M | $37.0M |
| Debt incl. finance leases | $2.2B | $2.0B | $2.1B | $1.9B | $1.6B |
| Net debt / EBITDA | 3.0x | 4.6x | 6.3x | 6.3x | 3.0x |
| Debt / equity | 1.2x | 1.1x | 1.3x | 1.2x | 1.0x |
| Interest coverage | 2.7x | 0.8x | 0.1x | β0.2x | 1.7x |
| Current ratio | 1.6x | 1.4x | 1.4x | 1.3x | 1.3x |
| Quick ratio | 0.6x | 0.5x | 0.5x | 0.5x | 0.5x |
| Total assets | $7.6B | $7.4B | $7.5B | $7.6B | $7.1B |
| Total liabilities | $5.8B | $5.7B | $5.9B | $6.0B | $5.5B |
| Shareholders' equity | $1.8B | $1.7B | $1.6B | $1.6B | $1.6B |
| Net debt (β = net cash) | $2.1B | $1.9B | $2.1B | $1.8B | $1.5B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.6M
1 insider
Sold, 12 months
$1.2M
4 insiders
Of sales under plans
20%
$0.2M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jun 23, 2026 | Mark BushwayPresident, Natural & CSCO | Sold | 10,000 | $51.56 | $0.5M | Form 4 |
| May 6, 2026 | Danielle BenedictChief Human Resources Officer | Sold plan | 4,807 | $52.00 | $0.2M | Form 4 |
| Jan 5, 2026 | James C PappasDirector | Bought | 2,000 | $33.30 | $0.1M | Form 4 |
| Jan 2, 2026 | James C PappasDirector | Bought | 15,000 | $33.76 | $0.5M | Form 4 |
| Dec 22, 2025 | Louis Anthony MartinPresident, Conventional & CCO | Sold | 9,439 | $34.67 | $0.3M | Form 4 |
| Dec 18, 2025 | Richard Eric EsperChief Accounting Officer | Sold | 4,261 | $33.08 | $0.1M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY24 | FY25 | FY26 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 4 / 9 | 4 / 9 | 6 / 9 |
| Accruals ratio | β4.9% | β7.8% | β6.2% |
| Altman Z'' | 1.70 | 1.39 | 1.66 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| United Natural Foods UNFI | $2.9B | β2.0% | 0.7% | 1.0% | 5.3% | β | 6 | |
| Casey's CASY | $25.9B | 10.2% | β | 4.1% | 13.6% | 33.7x | 7 | Compare β |
| Albertsons ACI | $6.8B | 3.5% | 0.9% | 0.6% | 5.5% | β | 5 | Compare β |
| Sprouts Farmers Market SFM | $6.3B | 14.1% | 7.8% | 5.3% | 46.9% | 12.7x | 7 | Compare β |
| Kroger KR | $40.6B | 0.4% | 1.3% | 2.3% | 7.6% | 37.1x | 4 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $9.3B | $10.2B | $22.3B | $26.6B | $27.0B | $28.9B | $30.3B | $31.0B | $31.8B | $31.2B |
| Gross profit | $1.4B | $1.5B | $3.2B | $3.9B | $3.9B | $4.2B | $4.1B | $4.2B | $4.2B | $4.2B |
| Operating income | $226M | $225M | β$196M | β$193M | $294M | $423M | $120M | $8.0M | β$31.0M | $211M |
| Interest expense | $16.8M | $16.0M | $181M | $192M | $204M | $155M | $144M | $162M | $146M | $126M |
| Pretax income | $214M | $210M | β$341M | β$342M | $183M | $310M | $7.0M | β$137M | β$154M | $102M |
| Income tax | $84.3M | $47.2M | β$59.0M | β$91.0M | $34.0M | $56.0M | β$23.0M | β$27.0M | β$39.0M | $18.0M |
| Net income | $130M | $163M | β$285M | β$274M | $149M | $248M | $24.0M | β$112M | β$118M | $84.0M |
| Diluted EPS | $2.56 | $3.20 | β$5.56 | β$5.10 | $2.48 | $4.07 | $0.40 | β$1.89 | β$1.95 | $1.34 |
| Diluted shares | 0.05B | 0.05B | 0.05B | 0.05B | 0.06B | 0.06B | 0.06B | 0.06B | 0.06B | 0.06B |
| Cash flow | ||||||||||
| Cash from operations | $273M | $109M | $285M | $457M | $614M | $331M | $624M | $253M | $470M | $540M |
| Capital expenditure | $56.1M | $44.6M | $228M | $173M | $310M | $251M | $323M | $345M | $231M | $217M |
| Free cash flow | $217M | $64.4M | $57.0M | $284M | $304M | $80.0M | $301M | β$92.0M | $239M | $323M |
| Depreciation and amortization | $86.1M | $87.6M | $248M | $282M | $285M | $285M | $304M | $319M | $321M | $303M |
| Stock-based compensation | $25.7M | $25.8M | $26.0M | $25.0M | $45.0M | $44.0M | $38.0M | $39.0M | $43.0M | $61.0M |
| Acquisitions | $9.2M | $0.0M | $2.3B | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Share buybacks | $0.0M | $24.2M | $0.0M | $0.0M | $0.0M | $0.0M | $62.0M | $0.0M | $0.0M | $50.0M |
| Dividends paid | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends and buybacks | $0.0M | $24.2M | $0.0M | $0.0M | $0.0M | $0.0M | $62.0M | $0.0M | $0.0M | $50.0M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $15.4M | $23.3M | $44.5M | $47.0M | $41.0M | $44.0M | $37.0M | $40.0M | $44.0M | $37.0M |
| Total debt | $162M | $309M | $2.8B | $2.4B | $2.2B | $2.1B | $2.0B | $2.1B | $1.9B | $1.6B |
| Finance lease liabilities | $0.0M | $0.0M | $133M | $156M | $142M | $36.0M | $23.0M | $19.0M | $16.0M | $13.0M |
| Current assets | $1.7B | $1.8B | $3.6B | $3.7B | $3.6B | $3.8B | $3.5B | $3.4B | $3.4B | $3.1B |
| Current liabilities | $704M | $699M | $2.1B | $2.4B | $2.5B | $2.4B | $2.4B | $2.4B | $2.6B | $2.4B |
| Inventory | $1.0B | $1.1B | $2.2B | $2.3B | $2.2B | $2.4B | $2.3B | $2.2B | $2.1B | $1.9B |
| Property and equipment, net | $602M | $571M | $1.9B | $1.7B | $1.8B | $1.7B | $1.8B | $1.8B | $1.7B | $1.7B |
| Total assets | $2.9B | $3.0B | $7.2B | $7.6B | $7.5B | $7.6B | $7.4B | $7.5B | $7.6B | $7.1B |
| Total liabilities | $1.2B | $1.1B | $5.7B | $6.4B | $6.0B | $5.8B | $5.7B | $5.9B | $6.0B | $5.5B |
| Shareholders' equity | $1.7B | $1.8B | $1.5B | $1.1B | $1.5B | $1.8B | $1.7B | $1.6B | $1.6B | $1.6B |
| Margins | ||||||||||
| Gross margin | 15.4% | 14.9% | 14.4% | 14.6% | 14.6% | 14.5% | 13.7% | 13.6% | 13.3% | 13.5% |
| Operating margin | 2.4% | 2.2% | β0.9% | β0.7% | 1.1% | 1.5% | 0.4% | 0.0% | β0.1% | 0.7% |
| EBITDA margin | 3.4% | 3.1% | 0.2% | 0.3% | 2.2% | 2.5% | 1.4% | 1.1% | 0.9% | 1.7% |
| Net margin | 1.4% | 1.6% | β1.3% | β1.0% | 0.6% | 0.9% | 0.1% | β0.4% | β0.4% | 0.3% |
| FCF margin | 2.3% | 0.6% | 0.3% | 1.1% | 1.1% | 0.3% | 1.0% | β0.3% | 0.8% | 1.0% |
| Returns | ||||||||||
| Return on capital | 7.8% | 8.8% | β4.7% | β3.8% | 6.4% | 9.0% | 3.2% | 0.2% | β0.7% | 5.3% |
| Return on capital employed | 10.2% | 10.1% | β5.4% | β3.8% | 5.7% | 8.3% | 2.4% | 0.2% | β0.6% | 4.4% |
| Return on equity | 8.1% | 9.2% | β17.0% | β20.7% | 11.2% | 15.0% | 1.4% | β6.6% | β7.4% | 5.3% |
| Return on assets | 4.5% | 5.6% | β5.6% | β3.7% | 2.0% | 3.3% | 0.3% | β1.5% | β1.6% | 1.1% |
| Growth | ||||||||||
| Revenue growth | 9.5% | 10.3% | 118.5% | 18.9% | 1.5% | 7.3% | 4.7% | 2.3% | 2.6% | β2.0% |
| Net income growth | 3.5% | 25.1% | β275.1% | β | β | 66.4% | β90.3% | β566.7% | β | β |
| EPS growth | 2.4% | 25.0% | β273.8% | β | β | 64.1% | β90.2% | β572.5% | β | β |
| FCF growth | β14.9% | β70.3% | β11.5% | 398.3% | 7.0% | β73.7% | 276.3% | β130.6% | β | 35.2% |
| Share count change | 0.8% | 0.1% | 0.7% | 5.1% | 11.5% | 1.7% | β0.5% | β2.3% | 1.5% | 4.3% |
| Financial health | ||||||||||
| Net debt / EBITDA | 0.5x | 0.9x | 55.9x | 28.5x | 4.0x | 3.0x | 4.6x | 6.3x | 6.3x | 3.0x |
| Debt / equity | 0.1x | 0.2x | 2.0x | 2.3x | 1.5x | 1.2x | 1.1x | 1.3x | 1.2x | 1.0x |
| Interest coverage | 13.5x | 14.0x | β1.1x | β1.0x | 1.4x | 2.7x | 0.8x | 0.1x | β0.2x | 1.7x |
| Current ratio | 2.4x | 2.6x | 1.7x | 1.6x | 1.4x | 1.6x | 1.4x | 1.4x | 1.3x | 1.3x |
| Quick ratio | 0.9x | 0.9x | 0.7x | 0.6x | 0.5x | 0.6x | 0.5x | 0.5x | 0.5x | 0.5x |
| Capital allocation | ||||||||||
| Capex / revenue | 0.6% | 0.4% | 1.0% | 0.7% | 1.2% | 0.9% | 1.1% | 1.1% | 0.7% | 0.7% |
| Stock comp / revenue | 0.3% | 0.3% | 0.1% | 0.1% | 0.2% | 0.2% | 0.1% | 0.1% | 0.1% | 0.2% |
| Payouts / FCF | 0.0% | 37.6% | 0.0% | 0.0% | 0.0% | 0.0% | 20.6% | β | 0.0% | 15.5% |
| Quality scores | ||||||||||
| Piotroski F-score | 5.0 | 5.0 | 3.0 | 5.0 | 5.0 | 7.0 | 6.0 | 4.0 | 4.0 | 6.0 |
| Altman Z'' | 5.6 | 6.2 | 1.9 | 1.5 | 1.9 | 2.4 | 1.9 | 1.7 | 1.4 | 1.7 |
| Accruals ratio | β5.0% | 1.8% | β11.2% | β9.9% | β6.2% | β1.1% | β8.0% | β4.9% | β7.8% | β6.2% |
Source: SEC EDGAR XBRL filings (CIK 0001020859). Data updated October 23, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.